Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies
FamLit_HF
2 other identifiers
interventional
328
1 country
1
Brief Summary
People with heart failure who do not take their medications as prescribed are at high risk of complications leading to hospitalization, death and poor quality of life. In the proposed intervention, nurses will use easy-to-understand language to coach patients and their care partners to help them work together and build skills to overcome their individual barriers to adherence in order to 1) improve and sustain patient medication adherence; 2) reduce hospitalization; 3) improve quality of life. If effective, this intervention will support long-term medication adherence, thus reducing hospitalizations related to heart failure and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 16, 2022
CompletedFirst Posted
Study publicly available on registry
September 21, 2022
CompletedStudy Start
First participant enrolled
January 4, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
May 5, 2026
April 1, 2026
4.5 years
September 16, 2022
April 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Medication adherence
Percentage of prescribed doses taken (PDT%) as determined by the electronic SimpleMed+ pillbox. SimpleMed+ will record the date and time that the lid of each compartment is opened and closed. Those data will be used to calculate objective medication adherence: percent prescribed doses taken (PDT%) = (# of doses taken during monitoring period)/(# of prescribed doses during monitoring period) x 100.PDT% ranges from 0-100%.
12 months
Self-reported medication adherence.
Adherence will be surveyed the Basel Assessment of Adherence Scale (BAAS), a copyrighted, self-reported scale. The BAAS includes 5 yes-no items and one visual analogue scale (VAS). If participants indicate they have missed a dose (a "yes" response) to any of 5 dichotomous items and \<80% on the VAS, they are classified as suboptimally medication adherent.
12 months
Secondary Outcomes (3)
Patient hospitalization
12 months
Quality of life - Minnesota Living with Heart Failure
12 months
Positive Affect
12 months
Other Outcomes (6)
Caregiver Burden
12 months
Numeracy health literacy
12 months
Health Literacy
12 months
- +3 more other outcomes
Study Arms (4)
Patients - Attention Only
ACTIVE COMPARATORPatients with a confirmed diagnosis of heart failure.
Care Partners - Attention Only
ACTIVE COMPARATORCare partners of patients with a confirmed diagnosis of heart failure.
Patients - FamLit
EXPERIMENTALPatients with a confirmed diagnosis of heart failure.
Care Partners - FamLit
EXPERIMENTALCare partners of patients with a confirmed diagnosis of heart failure.
Interventions
The FamLit (Family-focused and Literacy-sensitive strategy) is an interactive, multi-component intervention supported by the FamLit intervention Guide, including both spoken and printed materials written at a 4th-grade reading level for HF patients and their primary CPs.Three constructs guide the intervention, based on the Theory of Planned Behavior (TPB): 1) develop patient and CP positive attitudes through HF instruction and teach-back; 2) form positive subjective norms through coaching to improve patient and CP communication, support, and teamwork; and 3) increase perceived behavioral control through coaching and role-playing to empower patients and CPs to overcome individual barriers to adherence. This intervention also includes use of the SimpleMed+ electronic pillbox.
Participants in this group will talk with an interventionist to discuss general health. This intervention also includes use of the SimpleMed+ electronic pillbox.
Eligibility Criteria
You may qualify if:
- confirmed diagnosis of heart failure (HF), either systolic or diastolic HF
- ave suboptimal medication adherence
- have a care partner (CP) (either spouse, daughter/son, partner, other relative, friend) who is identified by the patient as the person most involved in HF care
- willingness to have a CP be involved in their medication taking
- have undergone evaluation of HF and prescribed stable doses of HF medications for at least 3 months
- live in a setting where the patient is responsible for their ow medication administration
- willing to use the SimpleMed+ (i.e., an electronic pillbox to measure objective medication adherence)
- availability by phone
You may not qualify if:
- cognitive impairment as indicated by having difficulties to understand and give informed consent
- a recent hospitalization within 3 months of study enrollment
- co-existing end-stage renal disease or terminal illness such as advanced malignancy, or any other condition with less than 1-year life expectancy
- psychotic illness
- current alcohol dependence or other substance abuse
- inability to speak English or other communication barrier
- currently or have received any similar self-care intervention recently in the past year
- unpaid family member, friend, partner, or other relation who is involved in the patients' care at least 3 times a week, designated by the patient
- willing to receive interventions with the patient together
- years of age or older
- cognitive impairment as indicated by having difficulties to understand and give informed consent
- coexisting terminal illness
- non-English speaking or any other communication barrier
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Institute of Nursing Research (NINR)collaborator
- Jia-Rong Wulead
Study Sites (1)
Jia-Rong Wu
Lexington, Kentucky, 40536, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jia-Rong Wu
University of Kentucky
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 16, 2022
First Posted
September 21, 2022
Study Start
January 4, 2023
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
May 5, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share